脱氮酶
泛素
蛋白酵素
癌变
癌基因
细胞生物学
下调和上调
细胞生长
生物
细胞周期
蛋白质降解
细胞凋亡
化学
癌症研究
癌症
生物化学
酶
遗传学
基因
作者
Xiao Dong,Zixin Liu,Encheng Zhang,Pingzhao Zhang,Yuqi Wang,Junjie Hang,Qi Li
标识
DOI:10.1016/j.cellsig.2021.110068
摘要
Deubiquitinating enzyme (DUB) can hydrolyze ubiquitin molecules from the protein bound with ubiquitin, and reversely regulate protein degradation. The ubiquitin-specific proteases (USP) family are cysteine proteases, which owns the largest members and diverse structure among the currently known DUB. The important roles of ubiquitin-specific peptidase39 (USP39) in cancer have been widely investigated. However, little is known about the putative de-ubiquitination function of USP39 in hepatocellular carcinoma (HCC) and the mechanisms of USP39 regulating tumor growth. Here, we used bioinformatics methods to reveal that USP39 expression is significantly upregulated in several cancer database. High expression of USP39 is correlated with poor prognosis of HCC patients. Then, we identify the specificity protein 1 (SP1), as a novel subtract of the USP39. We observe that USP39 stabilizes SP1 protein and prolongs its half-life by promoting its deubiquitylation pathway. In addition, our results show USP39 promotes cell proliferation by SP1-depenet manner in vivo and vitro. Knocking-down of USP39 promotes the cell apoptosis and arrest of the cell cycle, whereas SP1 forcefully reversed these effects. Taken together, our results suggest that USP39 participates the deubiquitylation of SP1 protein, providing new pathway for understand the upstream signaling for oncogene SP1.
科研通智能强力驱动
Strongly Powered by AbleSci AI